Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Auernhammer

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Endocrine Reviews|June 17, 2000
Leukemia-inhibitory factor-neuroimmune modulator of endocrine functionC J Auernhammer, S Melmed
The Journal of Clinical Investigation|December 19, 2001
The central role of SOCS-3 in integrating the neuro-immunoendocrine interfaceC J Auernhammer, S Melmed
Der Internist|December 21, 2017
[Functional diagnostics in endocrinology]C J Auernhammer, M Reincke
Endocrinology|March 31, 1999
Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axisC J Auernhammer, S Melmed
European Journal of Endocrinology|December 1, 1995
Effects of growth hormone and insulin-like growth factor I on the immune systemC J Auernhammer, C J Strasburger
Endocrine Connections|November 18, 2017
Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targetsE T Aristizabal Prada, C J Auernhammer
Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999
Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoterC J Auernhammer, C Bousquet, S Melmed
Endocrinology|May 16, 1998
Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axisC J Auernhammer, V Chesnokova, S Melmed
Endocrinology|May 16, 1998
Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress responseV Chesnokova, C J Auernhammer, S Melmed
Der Radiologe|May 2, 2003
[Primary hyperparathyroidism, adrenal tumors and neuroendocrine tumors of the pancreas--clinical diagnosis and imaging requirements]C J Auernhammer, D Engelhardt, B Göke
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Endocrine Reviews|June 17, 2000
Leukemia-inhibitory factor-neuroimmune modulator of endocrine functionC J Auernhammer, S Melmed
The Journal of Clinical Investigation|December 19, 2001
The central role of SOCS-3 in integrating the neuro-immunoendocrine interfaceC J Auernhammer, S Melmed
Der Internist|December 21, 2017
[Functional diagnostics in endocrinology]C J Auernhammer, M Reincke
Endocrinology|March 31, 1999
Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axisC J Auernhammer, S Melmed
European Journal of Endocrinology|December 1, 1995
Effects of growth hormone and insulin-like growth factor I on the immune systemC J Auernhammer, C J Strasburger
Endocrine Connections|November 18, 2017
Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targetsE T Aristizabal Prada, C J Auernhammer
Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999
Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoterC J Auernhammer, C Bousquet, S Melmed
Endocrinology|May 16, 1998
Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axisC J Auernhammer, V Chesnokova, S Melmed
Endocrinology|May 16, 1998
Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress responseV Chesnokova, C J Auernhammer, S Melmed
Der Radiologe|May 2, 2003
[Primary hyperparathyroidism, adrenal tumors and neuroendocrine tumors of the pancreas--clinical diagnosis and imaging requirements]C J Auernhammer, D Engelhardt, B Göke
Pageof 4